CAS No. 218600-53-4
| IUPAC Name | methyl (4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate | |
|---|---|---|
| CAS Number | 218600-53-4 | |
| Molecular Formula |
C32H43NO4 |
|
| Molecular Weight (MW) | 505.69 | |
| SMILES | CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C | |
| InChIKey | WPTTVJLTNAWYAO-KPOXMGGZSA-N |
Bardoxolone Methyl (RTA 402) is a synthetic oleanane triterpenoid that acts as an IκB kinase (IKK) inhibitor and Nrf2 activator. By inhibiting IKK and NF-κB signaling, it suppresses pro-inflammatory responses and promotes apoptosis in cancer cells. Concurrently, activation of the Nrf2 pathway enhances antioxidant gene expression, leading to cytoprotection and inhibition of ferroptosis. Through these dual pathways, Bardoxolone Methyl modulates cellular oxidative stress, survival, and autophagic responses. [1]
|
Concentration
Volume
Mass
|
|---|
| Solvent | Solubility & Note |
|---|---|
| DMSO |
26 mg/mL
(51.41 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
13 mg/mL
(25.7 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
50 mg/mL
(98.87 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
100 mg/mL
(197.74 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
20 mg/mL
(39.54 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- Bardoxolone Methyl (RTA 402) Mechanism of Action: NF-κB Inhibition in Renal Cell Research
- Bardoxolone Methyl (RTA 402) Clinical Trials
- Bardoxolone Methyl (RTA 402): Selectivity & Specificity
- Bardoxolone Methyl (RTA 402) Working Concentration | Cell Culture | Treatment
- Bardoxolone Methyl (RTA 402) Solubility in DMSO
- Bardoxolone Methyl (RTA 402) Stock Solution
- Bardoxolone Methyl (RTA 402) Storage
- Bardoxolone Methyl (RTA 402) Stability
- Bardoxolone Methyl (RTA 402) Combination Database
- Bardoxolone Methyl (RTA 402) Molecular Weight
- Bardoxolone Methyl (RTA 402) SMILES
- Bardoxolone Methyl (RTA 402) Chemical Structure (2D and 3D)
- Bardoxolone Methyl (RTA 402) IC50 for Cell-based and Cell-free Assays
- Bardoxolone Methyl (RTA 402) Cayman (11883)? Try a better option.
- Bardoxolone Methyl (RTA 402) MedChemExpress (HY-13324)? Try a better option.
- Bardoxolone Methyl (RTA 402) APExBIO (A3221)? Try a better option.
- Bardoxolone Methyl (RTA 402) Sigma (SMB00376)? Try a better option.
- Bardoxolone Methyl (RTA 402) SDS|MSDS